ArticleJournal of racial and ethnic health disparities2022
Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder.
Article in Journal of racial and ethnic health disparities, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 32 citations in OpenAlex.
- Stimulant use predicts high-risk substance use behaviors during medication treatment for opioid use disorder.Addictive behaviors · 2026Article
- Telemedicine and increased retention in medications for opioid use disorder treatment.Addiction science & clinical practice · 2026Article
- "The community's memory is timeless": exploring cultural and community context to inform the public health response to the overdose crisis in black communities.Harm reduction journal · 2026Article
- Statewide trends in access to medications for opioid use disorder (moud) among adolescents with opioid use disorders in Indiana.Drug and alcohol dependence reports · 2026Article
- Pain Neuroscience Education on Reducing Opioid Dependency in African American and Caucasian Populations: A Narrative Review.Journal of clinical medicine · 2025Review
- Exploring the Determinants of Treatment Completion Among Youth Who Received Medication-Assisted Treatment in the United States.Healthcare (Basel, Switzerland) · 2025Article
- Public perceptions of opioid misuse recovery and related resources in a nationally representative sample of United States adults.Addiction (Abingdon, England) · 2025Observational
- Cultural Competence Training Best Practices for Employment Support Professionals Serving People with Disabilities from Racial/Ethnic Minority Backgrounds with Co-occurring Opioid or Substance Use Disorders: A Scoping Review.Journal of rehabilitation · 2025Article
- Going Above and Beyond: Bridging the Gap Between Equitable Outcomes and Procedural Fairness in Health Policy Administration.Healthcare (Basel, Switzerland) · 2024Article
- Knowledge, experiences, and perceptions of medications for opioid use disorder among Black Kentuckians.Annals of medicine · 2024Article
- Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies.Expert review of pharmacoeconomics & outcomes research · 2024Review
- Piloting racial bias training for hospital emergency department providers treating patients with opioid use disorder.Health affairs scholar · 2024Article
- Strategies to Improve Patient-Centered Care for Drug Use-Associated Infective Endocarditis: JACC Focus Seminar 2/4.Journal of the American College of Cardiology · 2024Review
- Equity of overdose education and naloxone distribution provided in the Kentucky HEALing Communities Study.Drug and alcohol dependence reports · 2024Article
- Experiences of Stigma and Discrimination Compounded by Intersecting Identities among Individuals Receiving Medication for Opioid Use Disorder.Journal of health care for the poor and underserved · 2024Article
- Exploring potential moderators of depressive symptoms and treatment outcomes among patients with opioid use disorder.Addictive behaviors · 2023Article
- Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore.Journal of substance use and addiction treatment · 2023Article
- Social determinants of health and emergency department utilization among adults receiving buprenorphine for opioid use disorder.Drug and alcohol dependence reports · 2022Article
- From describing disparities to understanding why disparities exist: Anti-racist methods to support dental public health research.Journal of public health dentistry · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Largely due to structural racism, Black people with substance use disorder have worse outcomes than their White counterparts. The opioid epidemic has amplified these racial disparities. Little is known about strengths that buffer against the systemic issues that disproportionately impact Black adults with opioid use disorder (OUD), particularly those receiving buprenorphine for OUD. The objectives of this study are to (1) assess psychosocial and clinical predictors of OUD outcomes and (2) explore differences in OUD outcomes by gender among a sample of Black adults receiving buprenorphine. This is a secondary data analysis of a cross-sectional survey and medical record review with a convenience sample recruited from an addiction medicine clinic. Analyses included Black participants who provided at least one urine drug test during the study period (n = 98). Prospective 6-month OUD outcomes (treatment retention, substance use recurrence, and buprenorphine continuation) were abstracted from the medical record. Univariate analyses explored differences by gender. Multivariate regressions assessed predictors of OUD outcomes. Participants were 53% women and middle-aged (47 ± 12 years). The majority (59%) had been in treatment for at least 1 year at study enrollment. Substance use recurrence was common, but many individuals remained in treatment. OUD outcomes did not differ by gender. Older age and absence of injection opioid use history were significant predictors of treatment retention and buprenorphine continuation. When provided access to high-quality treatment, Black adults with OUD demonstrate positive outcomes. Addressing structural racism and developing culturally informed treatment interventions are necessary to improve access to high-quality care for this community.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.